Why the study?
Does shear stress stimulation differentially activate platelets in human versus bovine blood?
Does shear stress stimulation differentially activate platelets in human versus bovine blood?
Human blood is significantly more sensitive to shear stress-induced platelet activation than bovine blood, indicating bovine models may be inadequate for testing medical device hemocompatibility.
Answers are grounded in this paper and cite their sources.
Bovine models may underestimate human platelet activation by shear; leaves open validity of current hemocompatibility testing standards for cardiovascular devices.
As platelet activation plays a critical role in physiological hemostasis and pathological thrombosis, it is important in the overall hemocompatibility evaluation of new medical devices and biomaterials to assess their effects on platelet function. However, there are currently no widely accepted in vitro test methods to perform this assessment. In an effort to develop effective platelet tests for potential use in medical device evaluation, this study compared the sensitivity of platelet responses to shear stress stimulation of human and bovine blood using multiple platelet activation markers. Fresh whole blood samples anticoagulated with heparin or anticoagulant citrate dextrose, solution A (ACDA) were exposed to shear stresses up to 40 Pa for 2 min using a cone-and-plate rheometer model. Platelet activation was characterized by platelet counts, platelet surface P-selectin expression, and serotonin release into blood plasma. The results indicated that exposure to shear stresses above 20 Pa caused significant changes in all three of the platelet markers for human blood and that the changes were usually greater with ACDA anticoagulation than with heparin. In contrast, for bovine blood, the markers did not change with shear stress stimulation except for plasma serotonin in heparin anticoagulated blood. The differences observed between human and bovine platelet responses suggest that the value of using bovine blood for in vitro platelet testing to evaluate devices may be limited.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: